Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | S100A4 | P26447 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4400952 | 0.81 | KMT2A (0.62) | KMT2APOLBLMNAALDH1A1CA1 | |
| SCHEMBL4071279 | 0.81 | KMT2A (0.41) | KMT2ALMNAALDH1A1MEN1CYP3A4 | |
| SCHEMBL1169955 | 0.80 | CA1 (0.48) | KMT2ALMNAALDH1A1CA1CA2 | |
| SCHEMBL10289671 | 0.77 | KMT2A (0.58) | KMT2APOLBLMNAALDH1A1CA1 | |
| SCHEMBL4250031 | 0.77 | TSHR (0.47) | KMT2APOLBALDH1A1CA1CA2 | |
| SCHEMBL1958962 | 0.77 | KIF11 (0.51) | KMT2ABCHEACHECA1CA2 | |
| SCHEMBL9820153 | 0.74 | KMT2A (0.59) | KMT2APOLBBCHEACHELMNA | |
| SCHEMBL5745852 | 0.73 | BCHE (0.42) | KMT2ABCHEACHEALDH1A1CA1 | |
| SCHEMBL1169954 | 0.72 | ALDH1A1 (0.55) | KMT2AGLABCHEACHELMNA | |
| SCHEMBL14426922 | 0.72 | KMT2A (0.62) | KMT2APOLBLMNAALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572113-B1 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2017-05-17 | — | — | EP | disclosed |
| EP-1572113-B1 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9447100-B2 | Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents | TAKEDA PHARMACEUTICAL COMPANY, LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| US-9447100-B2 | Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents | TAKEDA PHARMACEUTICAL COMPANY, LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| US-9447100-B2 | Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents | TAKEDA PHARMACEUTICAL COMPANY, LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20140155416-A1 | SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-06-05 | — | — | US | disclosed |
| US-20140155416-A1 | SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-06-05 | — | — | US | disclosed |
| US-20140155416-A1 | SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-06-05 | — | — | US | disclosed |
| US-20090215746-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090215746-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090215746-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) | 2009-08-27 | — | — | US | disclosed |
| US-7514441-B2 | Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-07 | — | — | US | disclosed |
| US-7514441-B2 | Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-07 | — | — | US | disclosed |
| EP-1572113-A4 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2006-11-22 | — | — | EP | disclosed |
| US-20060079536-A1 | Calcium receptor modulating compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-04-13 | — | — | US | disclosed |
| EP-1572113-A2 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004017908-A2 | CALCIUM RECEPTOR MODULATING COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215746-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | CASR, NR2C2, RYR1 | KMT2A 3123/4885POLB 4328/4885GLA 3890/4885 |
| US-20060079536-A1 | Calcium receptor modulating compound and use thereof | CASR, NR2C2, CALCR | KMT2A 2825/4885POLB 4831/4885GLA 3570/4885 |
| US-20140155416-A1 | SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINES AS CALCIUM RECEPTOR MODULATING AGENTS | CASR, NR2C2, RYR1 | KMT2A 3123/4885POLB 4328/4885GLA 3890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.